SCHEMBL31542083

SCHEMBL31542083

COC(=O)c1ccc(Cc2nc3ccccc3c(=O)n2C)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.56
DRD2 P14416 2/20 0.55
TBXA2R P21731 2/20 0.55
HDAC6 Q9UBN7 2/20 0.55
HDAC8 Q9BY41 1/20 0.54
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
MAPK1 P28482 1/20 0.51
ACKR3 P25106 1/20 0.49
ALDH1A1 P00352 4/20 0.49
TNKS O95271 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
BLM P54132 1/20 0.47
KDM4E B2RXH2 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542057 0.86 HDAC6 (0.60) HDAC6HDAC8KMT2AACKR3ALDH1A1
SCHEMBL2881289 0.84 DRD2 (0.68) DRD2TBXA2RHDAC6NPC1RAB9A
SCHEMBL31542078 0.83 POLB (0.51) POLBDRD2TBXA2RKMT2AMEN1
SCHEMBL31542077 0.82 ALDH1A1 (0.57) POLBDRD2TBXA2RKMT2AMEN1
SCHEMBL31542082 0.82 POLB (0.63) POLBDRD2TBXA2RKMT2AMEN1
SCHEMBL31542084 0.82 ALDH1A1 (0.78) POLBKMT2AMEN1ALDH1A1NPC1
SCHEMBL403865 0.77 ALDH1A1 (0.48) DRD2TBXA2RHDAC6HDAC8KMT2A
SCHEMBL2883864 0.77 DRD2 (0.71) POLBDRD2TBXA2RKMT2AMEN1
SCHEMBL3518718 0.75 KMT2A (0.67) POLBKMT2AMEN1TNKSNPC1
SCHEMBL3969671 0.74 KDM4E (0.61) POLBKMT2AMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP disclosed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO disclosed